These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32551021)

  • 1. ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model.
    Iwaki Y; Ohhata A; Nakatani S; Hisaichi K; Okabe Y; Hiramatsu A; Watanabe T; Yamamoto S; Nishiyama T; Kobayashi J; Hirooka Y; Moriguchi H; Maeda T; Katoh M; Komichi Y; Ota H; Matsumura N; Okada M; Sugiyama T; Saga H; Imagawa A
    ACS Med Chem Lett; 2020 Jun; 11(6):1335-1341. PubMed ID: 32551021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism.
    Bao L; Qi J; Wang YW; Xi Q; Tserennadmid T; Zhao PF; Qi J; Damirin A
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1911-1918. PubMed ID: 30064908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
    J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
    Black KE; Berdyshev E; Bain G; Castelino FV; Shea BS; Probst CK; Fontaine BA; Bronova I; Goulet L; Lagares D; Ahluwalia N; Knipe RS; Natarajan V; Tager AM
    FASEB J; 2016 Jun; 30(6):2435-50. PubMed ID: 27006447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.
    Ragle LE; Palanisamy DJ; Joe MJ; Stein RS; Norman DD; Tigyi G; Baker DL; Parrill AL
    Bioorg Med Chem; 2016 Oct; 24(19):4660-4674. PubMed ID: 27544588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autotaxin inhibitors: a patent review.
    Barbayianni E; Magrioti V; Moutevelis-Minakakis P; Kokotos G
    Expert Opin Ther Pat; 2013 Sep; 23(9):1123-32. PubMed ID: 23641951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis.
    Samadi N; Gaetano C; Goping IS; Brindley DN
    Oncogene; 2009 Feb; 28(7):1028-39. PubMed ID: 19079345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and optimization of boronic acid based inhibitors of autotaxin.
    Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H
    J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
    Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
    J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.
    Salgado-Polo F; Fish A; Matsoukas MT; Heidebrecht T; Keune WJ; Perrakis A
    J Biol Chem; 2018 Sep; 293(37):14312-14327. PubMed ID: 30026231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Structural Binding Mode of the Four Autotaxin Inhibitor Types that Differentially Affect Catalytic and Non-Catalytic Functions.
    Salgado-Polo F; Perrakis A
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood.
    Endo T; Kano K; Motoki R; Hama K; Okudaira S; Ishida M; Ogiso H; Tanaka M; Matsuki N; Taguchi R; Kanai M; Shibasaki M; Arai H; Aoki J
    J Biochem; 2009 Aug; 146(2):283-93. PubMed ID: 19416959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma.
    Murph MM; Jiang GW; Altman MK; Jia W; Nguyen DT; Fambrough JM; Hardman WJ; Nguyen HT; Tran SK; Alshamrani AA; Madan D; Zhang J; Prestwich GD
    Bioorg Med Chem; 2015 Sep; 23(17):5999-6013. PubMed ID: 26190462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel 2-pyrrolidinone and pyrrolidine derivatives and study of their inhibitory activity against autotaxin enzyme.
    Gerokonstantis DT; Nikolaou A; Magkrioti C; Afantitis A; Aidinis V; Kokotos G; Moutevelis-Minakakis P
    Bioorg Med Chem; 2020 Jan; 28(2):115216. PubMed ID: 31864778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzoxaboroles-Novel Autotaxin Inhibitors.
    Kraljić K; Jelić D; Žiher D; Cvrtila A; Dragojević S; Sinković V; Mesić M
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31547058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.
    North EJ; Howard AL; Wanjala IW; Pham TC; Baker DL; Parrill AL
    J Med Chem; 2010 Apr; 53(8):3095-105. PubMed ID: 20349977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation.
    Ortlepp C; Steudel C; Heiderich C; Koch S; Jacobi A; Ryser M; Brenner S; Bornhäuser M; Brors B; Hofmann WK; Ehninger G; Thiede C
    Exp Hematol; 2013 May; 41(5):444-461.e4. PubMed ID: 23377000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes.
    Honjo M; Igarashi N; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Weinreb RN; Aihara M
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):693-701. PubMed ID: 29392315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.